QT
NAMS icon

Quantbot Technologies’s NewAmsterdam Pharma NAMS Stock Holding History

Quantbot Technologies’s Portfolio NAMS Stock Details NAMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.3K Buy
+2,694
New +$88.8K ﹤0.01% 1485
2026
Q1 		– Sell
-3,692
Closed -$130K – 2005
2025
Q4 		$130K Buy
+3,692
New +$134K ﹤0.01% 1359

Other funds holding NAMS

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

Quantbot Technologies's NAMS Position: Q2 2026 in Review

Quantbot Technologies opened a new position in NewAmsterdam Pharma (NAMS) in Q2 2026: 2,694 shares worth $91.3K. The stake represents ﹤0.01% of the portfolio and ranks #1485 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in NAMS as recently as Q4 2025.

Quantbot Technologies first reported a position in NAMS in Q4 2025 and has held it in 2 quarters since. The position peaked at $130K in Q4 2025. 195 funds tracked by Wall St. Rank hold NAMS as of Q2 2026.

  • Quantbot Technologies held 2,694 shares of NewAmsterdam Pharma worth $91.3K as of Q2 2026.
  • NewAmsterdam Pharma was a new Quantbot Technologies position in Q2 2026.
  • NewAmsterdam Pharma made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1485 holding.
  • Quantbot Technologies first reported a position in NewAmsterdam Pharma in Q4 2025 and has held it in 2 quarters since.
  • Quantbot Technologies's NewAmsterdam Pharma position peaked at $130K in Q4 2025.
  • 195 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.